Healthcare will be disrupted by wearable technologies. To gain capabilities to participate and shape this future, Johnson & Johnson has entered into a collaborative arrangement with Apple to understand how these technologies permit new ways of generating health evidence and delivering health value into the market. John Whang, Head of Integrated Evidence in Cardiovascular and Metabolism at Johnson & Johnson, spoke on the topic at the 2019 Successful Applications of Analytics conference. The annual conference is one of the leading events in the analytics industry, attracting data executives from top tech and Fortune 500 companies.